Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study
Early treatment may prevent or delay the onset of type 2 diabetes mellitus (T2DM) in individuals who are at high risk. Lifestyle interventions and the hypoglycemic drug metformin have been shown to reduce T2DM incidence. The effectiveness of such interventions may be enhanced by targeting environmen...
Main Authors: | Talia Palacios, Luis Vitetta, Samantha Coulson, Claire D. Madigan, Yan Y. Lam, Rachel Manuel, David Briskey, Chelsea Hendy, Ji-Nu Kim, Thomas Ishoey, Maria J. Soto-Giron, Eric M. Schott, Gerardo Toledo, Ian D. Caterson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/7/2041 |
Similar Items
-
A retrospective descriptive study of pain scores in the pre-diabetic patients on metformin
by: Moore, Michele Nakamura
Published: (2016) -
Metformin Preserves β-Cell Compensation in Insulin Secretion and Mass Expansion in Prediabetic Nile Rats
by: Hui Huang, et al.
Published: (2021-01-01) -
The effects of metformin on immune cell function in prediabetic patients
by: Persky, Leah B.
Published: (2018) -
Role of Voglibose in the Treatment of Prediabetes in Indian Population: A Cross-Speciality Survey
by: Pavitra Raj Dewda, et al.
Published: (2013-10-01) -
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
by: Celestino Sardu, et al.
Published: (2019-09-01)